Aptorum Group Limited is a biopharmaceutical and life sciences company focused on researching and developing innovative healthcare products through its wholly-owned subsidiaries. The company conducts research and development activities in biopharmaceutical product candidates and diagnostic tests, while also maintaining long-term investment holdings in non-marketable securities including equity stakes in companies developing treatments for serious diseases. The company generates revenue and sustains operations through equity and debt financing arrangements, with profitability dependent on successfully developing, obtaining regulatory approval for, and commercializing its product candidates in competitive healthcare markets.